CD163 and metabolic dysfunction-associated steatotic liver disease: These controls are of course “imperfect” because of signs of hepatic necro-inflammation, as demonstrated by the presence of CD163-positive cells similar NASH+ samples, but their hepatocyte expression of Klotho co-receptor remains statistically higher than NAFLD and NASH (Table 3).